CQS Cayman’s Alpine Immune Sciences Inc ALPN Stock Holding History

CQS Cayman’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-15,000	Closed	-$909K	–	201
2015 Q2	$909K	Buy	+15,000	New	+$893K	0.05%	141

Other funds holding ALPN

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CQS Cayman's ALPN Position: Q3 2015 in Review

CQS Cayman sold out of Alpine Immune Sciences Inc (ALPN) in Q3 2015, closing a stake of 15,000 shares — an estimated $909K sold.

CQS Cayman first reported a position in ALPN in Q2 2015 and held it in 1 quarter. The position peaked at $909K in Q2 2015. 63 funds tracked by Wall St. Rank hold ALPN as of Q3 2015.

CQS Cayman reported no remaining Alpine Immune Sciences Inc position as of Q3 2015 after selling out during the quarter.
CQS Cayman sold 15,000 Alpine Immune Sciences Inc shares in Q3 2015, an estimated $909K.
CQS Cayman first reported a position in Alpine Immune Sciences Inc in Q2 2015 and held it in 1 quarter.
CQS Cayman's Alpine Immune Sciences Inc position peaked at $909K in Q2 2015.
63 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q3 2015.

Based on CQS Cayman's 13F filing for Q3 2015, filed 30 Oct 2015.